Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

JPMorgan cuts Keysight shares target on margin concerns

EditorEmilio Ghigini
Published 28/05/2024, 08:28 pm
KEYS
-

On Tuesday, JPMorgan (NYSE:JPM) adjusted its outlook on Keysight Technologies (NYSE:KEYS) shares, reducing the company's price target from $162.00 to $156.00, while maintaining a Neutral rating on the stock.

The firm cited approaching lows in the company's core business and modest quarterly revenue declines as factors in the revision. The expected revenue dip from the second fiscal quarter to the third is projected to be around 2%, with hopes of a rebound by the end of the fourth fiscal quarter, aligning with typical seasonal patterns.

The analyst pointed out that investor confidence might be wavering not due to these slight declines, but rather because of unexpected margin outcomes within the Electronic Industrial Solutions Group (EISG).

The segment's gross and operating margins have seen significant quarter-over-quarter drops, which deviates from Keysight's historically stable results. This unpredictability, coupled with conflicting signals regarding the fiscal year 2025 outlook, has contributed to investor unease.

While the company anticipates a delay in market recovery, it also suggests that a strong rebound in equipment demand is likely, following previous pullbacks.

Looking at the financials, JPMorgan has slightly increased its fiscal year 2024 revenue estimates for Keysight after a solid second-quarter performance, aligning its earnings forecasts with the sell-side consensus.

However, the focus now shifts to fiscal year 2025, where current consensus estimates predict a 7% revenue growth and a 19% increase in earnings per share (EPS).

These figures are seen as overly optimistic by JPMorgan, considering the potential prolonged macroeconomic effects into the latter half of 2024 or early fiscal year 2025.

JPMorgan's own projections for Keysight are more conservative, forecasting a 4% revenue growth and a 9% rise in EPS, which fall below the company's long-term targets of 5%-7% for revenue and at least 10% for EPS growth.

The firm believes that adjusting and lowering investor expectations for fiscal year 2025 is a necessary step for Keysight's shares to stabilize moving forward.

Consequently, JPMorgan has also reduced its fiscal year 2025 EPS estimate for Keysight to $6.50 from the previous $6.70, reflecting the anticipated margin pressures.

InvestingPro Insights

With the recent outlook adjustment by JPMorgan on Keysight Technologies, investors may find additional context in real-time data and analysis. According to InvestingPro, analysts have revised their earnings downwards for the upcoming period, indicating caution in the short-term financial performance of the company. This aligns with JPMorgan's conservative forecast and the expectation of margin pressures. Moreover, despite a solid performance in the second quarter, analysts anticipate a sales decline in the current year, adding to the concerns outlined by JPMorgan regarding the fiscal year 2025 outlook.

The current market capitalization of Keysight stands at $25.14 billion, with a P/E ratio of 31.3, reflecting investor valuation of the company's earnings. The revenue for the last twelve months as of Q2 2024 was reported at $5.168 billion, with a notable gross profit margin of 64.16%. These figures suggest that while the company is facing headwinds, it retains a strong profit-generating capability. Additionally, Keysight's stock generally trades with low price volatility, which might appeal to investors looking for stability in their portfolio.

For those seeking further insights, InvestingPro offers additional tips on Keysight Technologies, which can be accessed through their platform. By using the coupon code PRONEWS24, readers can get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking a wealth of investment information and analysis. There are currently 8 more InvestingPro Tips available for Keysight Technologies, offering a deeper dive into the company's financial health and market performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.